Delivery Order SPE2DB20D1100-SPE2DB24FC0U9

Award Date 6/3/24
Potential Completion Date 6/25/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $12,595 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to supply 400mg vials of the specialty pharmaceutical product BENLYSTA. The award is not set aside. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
This is a $5,038.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 400 MG VIALS. The award has an ultimate completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 400 MG VIALS. The $5,038.00 firm fixed price contract has a period of performance through November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical to provide a comprehensive range of medical commodities supporting...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $12,595.00, is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product. The contract has no set-aside designation and is a Firm Fixed Price contract. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,259.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 400 mg vials of BENLYSTA, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical through December 31, 2025. The IDC enables DLA to efficiently procure a range of pharmaceutical products and medical supplies...
This is a $8,379.09 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to support military treatment programs and facilities. The contract has an ultimate completion date of September 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,896.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of BENLYSTA 120 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
This is a $11,168.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The order has a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medications to support military treatment programs and federal healthcare providers nationwide. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,519.00 firm-fixed price contract is for the provision of BENLYSTA 400 mg vials, a pharmaceutical product. The contract has a completion date of June 11, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distribution companies in the world, holds a significant...
This is a federal delivery order contract award to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA). The contract is for the supply of BENLYSTA 400 mg vials, a pharmaceutical product used in the treatment of chronic conditions. The contract has a ceiling value of $13,854.50 and a period of performance through May 28, 2024. It is a firm fixed-price contract, with no set-aside designation used. Amerisourcebergen, a major pharmaceutical distribution...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC0U9
    Delivery Order

This is a $12,595.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of BENLYSTA 400 MG VIALS, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, has significant Indefinite Delivery Contracts (IDCs) with both the DLA and the Department of Justice Federal Bureau of Investigation to provide a wide range of pharmaceutical products and medical supplies to support government healthcare programs and facilities, including those serving the U.S. Armed Forces. This specific delivery order has a ceiling value of $12,595.00 and an ultimate completion date of June 25, 2024.

Generated 9/2/24, 3:28 PM